Evidence map›Paper›PMID 31545458›Full record

ArticleOncology reports2019

LINC00461 affects the survival of patients with renal cell carcinoma by acting as a competing endogenous RNA for microRNA‑942.

Yicheng Chen, Jinkui He, Changju Su, Huan Wang, Yuanlei Chen, Wenhao Guo, Yining Li, Guoqing Ding

Open access · hybridAbstract read
In one paragraph

Article in Oncology reports, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
1.2field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 23 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Competing endogenous RNAs (ceRNAs) and drug resistance to cancer therapy.Cancer drug resistance (Alhambra, Calif.) · 2024
    Review
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 1 country.

Yicheng ChenDepartment of Urology, Sir Run‑Run Shaw Hospital, College of Medicine, Zhejiang University, Hangzhou 310016, P.R. China.
Jinkui HeDepartment of Urology, Yiwu Traditional Chinese Medicine Hospital, Yiwu 322000, P.R. China.
Changju SuDepartment of Urology, Yiwu Traditional Chinese Medicine Hospital, Yiwu 322000, P.R. China.
Huan WangDepartment of Urology, Sir Run‑Run Shaw Hospital, College of Medicine, Zhejiang University, Hangzhou 310016, P.R. China.
Yuanlei ChenDepartment of Urology, Sir Run‑Run Shaw Hospital, College of Medicine, Zhejiang University, Hangzhou 310016, P.R. China.
Wenhao GuoThe Second Clinical Medical College of Fujian Medical University, Quanzhou 362000, P.R. China.
Yining LiThe Second Clinical Medical College of Fujian Medical University, Quanzhou 362000, P.R. China.
Guoqing DingDepartment of Urology, Sir Run‑Run Shaw Hospital, College of Medicine, Zhejiang University, Hangzhou 310016, P.R. China.
Sir Run Run Shaw Hospital · CNFujian Medical University · CNSecond Affiliated Hospital of Fujian Medical University · CNZhejiang University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The present study aimed to investigate the potential mechanisms of human miR‑942 in the sunitinib‑resistance of renal cell carcinoma (RCC). A sunitinib‑resistant OS‑RC‑2 cell line was established by continuous exposure to increasing concentrations of sunitinib for ~12 weeks. The expression levels of four miRNAs were determined by reverse transcription‑quantitative (RT‑q)PCR. miR‑942 mimics were transfected into OS‑RC‑2 cells and RNA sequencing was performed on the miR‑942‑ and negative control‑transfected cells. Downregulated genes, including those of long non‑coding RNAs (lncRNAs) and mRNAs, were identified. The target genes of miR‑942 were predicted, followed by protein‑protein interaction network construction and functional enrichment analyses of miR‑942 target genes. In addition, RCC RNA‑seq and miRNA‑seq data were downloaded from The Cancer Genome Atlas (TCGA) database. The contributions of lncRNA and/or mRNAs to survival prediction were assessed and a competing endogenous RNA (ceRNA) network consisting of miR‑942, lncRNA and mRNAs was constructed. The expression levels of LINC00461, miR‑942, spalt‑like transcription factor 1 (SALL1), methionyl aminopeptidase 1 (METAP1) and DDB1 and CUL4 associated factor 1 (DCAF11) were verified using RT‑qPCR. The role of LINC00461 in cell viability was detected by MTT assay. The expression level of miR‑942 was significantly increased in sunitinib‑resistant cells. A total of seven lncRNAs and 155 mRNAs were predicted as target genes of miR‑942 in the miR‑942 mimic‑treated samples, compared with the mimic control‑treated group. These potential target genes were significantly associated with 'protein binding', 'TNF‑β signaling pathway', 'negative transcriptional regulation' and 'RNA binding'. Through the integrated analysis of RNA‑sequencing and TCGA data, an miR‑942‑related ceRNA network, which was predicted to significantly affect the survival of patients with RCC, was constructed. The expression levels of lncRNA LINC00461 and the genes SALL1, METAP1, and DCAF11 were further verified. The viability of OS‑RC‑2 cells was decreased following co‑transfection with miR‑942 mimics and LINC00641 siRNA, and was comparable to that of wild type OS‑RC‑2 cells (P>0.05). Therefore, lncRNA LINC00461 may act as an miR‑942 ceRNA, and affect the survival of patients with RCC by regulating the expression of SALL1, METAP1 and DCAF11.

Indexed as

Drug Resistance, NeoplasmAminopeptidasesCarcinoma, Renal CellCell Line, TumorGene Expression ProfilingGene Expression Regulation, NeoplasticHumansKidney NeoplasmsMicroRNAsPrognosisProtein Interaction MapsRNA, Long NoncodingSequence Analysis, RNASunitinibSurvival AnalysisTranscription FactorsAminopeptidasesDDB1 and CUL4 associated factor 11, humanMETAP1 protein, humanMicroRNAsMIRN942 microRNA, humanRNA, Long NoncodingSALL1 protein, humanSunitinibTranscription FactorsUbiquitin-Protein Ligase Complexes

Identifiers

PMID31545458
PMCPMC6775798
OpenAlexW2973151707

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.